Jennifer Su
Dermatology · Augusta, GANPI 1992468474
Payments from drug & device makers
Across 155 payments — averaging $51.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$897
- Johnson & Johnson$787
- Novartis$750
- Incyte Corporation$627
- Lilly USA, LLC$582
- Regeneron Healthcare Solutions, Inc.$513
- plus $4K from 18 others
What the payments were for
- Food & beverage$7,42793%
- Education$5587%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $897 |
| Johnson & Johnson(2 entities) | 19 | $787 |
| Novartis | 9 | $750 |
| Incyte Corporation | 6 | $627 |
| Lilly USA, LLC | 12 | $582 |
| Regeneron Healthcare Solutions, Inc. | 13 | $513 |
| UCB, Inc. | 6 | $499 |
| Amgen | 16 | $468 |
| Sanofi | 13 | $365 |
| Janssen Scientific Affairs, LLC | 4 | $358 |
| Sun Pharmaceutical Industries Inc. | 9 | $344 |
| Pfizer | 8 | $282 |
| Galderma Laboratories, L.p. | 2 | $282 |
| Almirall LLC | 4 | $281 |
| Boehringer Ingelheim | 2 | $229 |
| E.r. Squibb & Sons, L.L.C. | 3 | $200 |
| Arcutis Biotherapeutics, Inc. | 2 | $158 |
| Organon | 1 | $144 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Dermavant Sciences, Inc. | 1 | $55 |
| LEO Pharma Inc. | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,986 in reported general payments places this provider in the 65th percentile of 345 dermatology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 16 | $349,535 |
| Skyrizi PenRisankizumab-Rzaa | 11 | $219,189 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 20 | $144,594 |
| Dupixent SyringeDupilumab | 39 | $140,711 |
| Taltz AutoinjectorIxekizumab | 20 | $125,401 |
| OtezlaApremilast | 23 | $78,108 |
| Dapsone | 13 | $2,697 |
| Calcipotriene | 27 | $2,642 |
| Tacrolimus | 13 | $1,760 |
| Fluorouracil | 16 | $1,251 |
| Clobetasol Propionate | 45 | $1,008 |
| Doxycycline Hyclate | 35 | $975 |
| Hydrocortisone | 36 | $618 |
| Ketoconazole | 28 | $474 |
| Triamcinolone Acetonide | 42 | $286 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $468 | $78,10823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 345 dermatology providers in Georgia.
Other dermatology in Augusta
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Tiffani HamiltonAlpharetta$3.3M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Mark KnautzPowder Springs$1.7M
- Gerald SlagelFayetteville$1.2M
- Zakiya RiceAtlanta$1.1M
- Corinne HowingtonSavannah$874K
- Alia BrownSnellville$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.